Clinical Trial Update: Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures [Phase 2, Phase 3]

View source ↗

Summary

A long-term safety and tolerability update of TRI476 (oxcarbazepine) in children with inadequately controlled partial onset seizures from a Phase 2/3 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Seizures

Drugs mentioned

• TRI476 (oxcarbazepine)

Snippet

Sponsor: Nobelpharma | Conditions: Partial Onset Seizures | Phase 2, Phase 3 | Status: COMPLETED